FIELD: pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and medicine. Invention discloses two methods of purifying desmopressin using low- and high-pressure liquid chromatography techniques.
EFFECT: methods provides removal of hard-to-remove impurities.
6 cl, 1 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PURIFYING GOSERELIN | 2015 |
|
RU2578414C1 |
METHOD OF PURIFYING TRIPTORELIN | 2015 |
|
RU2585105C1 |
METHOD OF CHROMATOGRAPHIC PURIFICATION OF OCTREOTIDE | 2010 |
|
RU2441018C1 |
METHOD OF INDUSTRIAL PURIFICATION OF ROMIPLOSTIM | 2021 |
|
RU2804622C2 |
CRYSTAL BETA-MODIFICATION OF (E)-DIMETHYL BUTENEDIOATE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION ON ITS BASIS | 2016 |
|
RU2616605C1 |
METHOD OF CHROMATOGRAPHIC PURIFICATION OF BUSERELIN | 2007 |
|
RU2332248C1 |
CRYSTALLINE B-MODIFICATION OF BENZYLDIMETHYL[3- (MYRISTOYLAMINO)PROPYL]AMMONIUM OF MONOHYDRATE CHLORIDE, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2016 |
|
RU2626877C1 |
CRYSTALLINE H-MODIFICATION OF 2-AMINO-2-(2-(4-OCTYLPHENYL) ETHYL)PROPANE-1,3-DIOLE HYDROCHLORIDE, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2016 |
|
RU2627691C1 |
METHOD FOR PURIFICATION OF RECOMBINANT IL-36RA (EMBODIMENTS) | 2018 |
|
RU2700751C1 |
CRYSTALLINE β-MODIFICATION OF 3-(4-AMINO-1-OXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE, METHOD OF ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2016 |
|
RU2616976C1 |
Authors
Dates
2016-04-10—Published
2015-03-26—Filed